Trials / Conditions / Extensive Stage Lung Small Cell Cancer
Extensive Stage Lung Small Cell Cancer
5 registered clinical trials studyying Extensive Stage Lung Small Cell Cancer — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS NCT07203053 | ETOP IBCSG Partners Foundation | Phase 2 |
| Recruiting | Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer NCT07057791 | PrECOG, LLC. | Phase 2 |
| Not Yet Recruiting | Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Ca NCT07172412 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Not Yet Recruiting | Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell L NCT07061535 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 2 |
| Recruiting | Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC NCT06350162 | Zhejiang Cancer Hospital | Phase 2 |